{
    "clinical_study": {
        "@rank": "119283", 
        "arm_group": [
            {
                "arm_group_label": "0.454% stannous fluoride dentifrice", 
                "arm_group_type": "Experimental", 
                "description": "Participants to brush whole mouth with 1-inch strip of the test dentifrice (0.454% SnF) for one timed minute, followed by rinsing with 5 milliliter (mL) of water."
            }, 
            {
                "arm_group_label": "0.76% sodium monofluorophosphate dentifrice", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants to brush whole mouth with 1-inch strip of the control dentifrice (0.76% NaMFP) for one timed minute, followed by rinsing with 5 mL of water."
            }
        ], 
        "brief_summary": {
            "textblock": "Clinical studies have demonstrated long term relief from dentine hypersensitivity with twice\n      daily brushing of a toothpaste containing stannous fluoride in comparison to marketed\n      (negative) controls.  The aim of this study is to evaluate the effectiveness of a stannous\n      fluoride dentifrice in the treatment of dentinal hypersensitivity compared to a marketed\n      (negative) control, over a period of 56 days (8 weeks) with twice daily brushing."
        }, 
        "brief_title": "Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Dentine Hypersensitivity", 
        "condition_browse": {
            "mesh_term": [
                "Dentin Sensitivity", 
                "Hypersensitivity"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants with self-reported history of dentinal hypersensitivity lasting more\n             than 6 months but not more than 10 years.\n\n          -  Participants with minimum of 20 natural teeth.\n\n          -  At screening, a minimum of two accessible teeth (incisors, canines, premolars) that\n             meet all of the following criteria.\n\n               1. Teeth showing signs of facial/cervical gingival recession and/or signs of\n                  erosion or abrasion.\n\n               2. Teeth with Gingival Index score \u22641 and a clinical mobility of \u22641.\n\n               3. Teeth that are determined to be sensitive by the subject following a 1 second\n                  air blast to the cervical margin.\n\n        Exclusion Criteria:\n\n          -  Presence of chronic debilitating disease which, in the opinion of the investigator,\n             could affect study outcomes.\n\n          -  Any condition which, in the opinion of the investigator, causes dry mouth.\n\n          -  Tooth with evidence of current or recent caries, or reported treatment of decay in 12\n             months of screening.\n\n          -  Participant using of a desensitising dentifrice within 6 weeks of screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "119", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827670", 
            "org_study_id": "RH01685"
        }, 
        "intervention": [
            {
                "arm_group_label": "0.454% stannous fluoride dentifrice", 
                "description": "Test dentifrice containing 0.454% SnF", 
                "intervention_name": "Stannous fluoride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "0.76% sodium monofluorophosphate dentifrice", 
                "description": "Control dentifrice containing 0.76% w/w Sodium Monofluorophosphate [1000 parts per million (ppm) fluoride]", 
                "intervention_name": "Sodium monofluorophosphate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluorides", 
                "Tin Fluorides", 
                "Fluorophosphate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Wayne", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "46825"
                }, 
                "name": "Salus Research, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "An evaporative air stimulus will be administered using a dental triple air syringe. Response to this stimulus will be evaluated using the Schiff Sensitivity Scale.", 
            "measure": "Mean change from baseline in Schiff sensitivity score", 
            "safety_issue": "No", 
            "time_frame": "Baseline to Week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827670"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "A tactile stimulus will be administered using a constant pressure probe (Yeaple Probe) which allows the examiner to vary the force applied to the dentin surface of the tooth.", 
                "measure": "Mean change from baseline in Tactile Sensitivity", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 4, Week 8"
            }, 
            {
                "description": "An evaporative air stimulus will be administered using a dental triple air syringe. Response to this stimulus will be evaluated using the Schiff Sensitivity Scale.", 
                "measure": "Mean change from baseline in Schiff sensitivity score", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 4"
            }, 
            {
                "description": "Participants will rate the intensity of their response to the stimulus using a 10 point VAS ranging from 1 (no pain) to 10 (intense pain).", 
                "measure": "Mean change from baseline in tooth sensitivity on a Visual Analogue Scale (VAS)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 4, Week 8"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}